Pacific Biosciences of California (PACB) — Cash Flow Reinvestment Rate
Pacific Biosciences of California (PACB) has a Cash Flow Reinvestment Rate of 0.72x as of March 2020, reinvesting $54.33 Million (capex $117.00K plus investments $-54.21 Million) from operating cash flow of $75.36 Million. See Pacific Biosciences of California free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacific Biosciences of California Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Pacific Biosciences of California across 1 annual periods. For the full cash flow conversion analysis, see Pacific Biosciences of California (PACB) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Pacific Biosciences of California (2020–2020)
Year-by-year capital reinvestment analysis for Pacific Biosciences of California. See Pacific Biosciences of California (PACB) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 11.25x | $219.32 Million | $19.50 Million | $1.04 Million | — |